Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of ANKIB1 mRNA | increases expression | 20458559
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANKIB1 mRNA | decreases expression | 19150397
|
C053541 |
bicalutamide |
bicalutamide results in increased expression of ANKIB1 mRNA | increases expression | 16631469
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ANKIB1 mRNA | increases expression | 20106945
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ANKIB1 mRNA | affects cotreatment|increases expression | 17183730
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ANKIB1 mRNA | increases expression | 19465110
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ANKIB1 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.66 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.66 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.21 | 19490988 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.34 | 11798837 19825857 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.77 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.68 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.79 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 19460635 18316065 18177632 17507914 16609825 17688650 18940202 17157402 18775368 19232924 18558336 20603192 18396377 15238991 18985861 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.20 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
9.92 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.92 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.57 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.57 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.68 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.63 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
1.97 | 16217749 14691202 15073043 15553829 11135700 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.32 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.38 | 12490120 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.17 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.17 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.79 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.12 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 15340226 15668235 12621046 16354765 8697196 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.51 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.90 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.90 | 8888407 17688650 16575769 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.40 | 15213294 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.99 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.99 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.35 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.65 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.51 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.36 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.06 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.84 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.66 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.46 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.66 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.66 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
14.84 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.84 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
14.84 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.33 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.46 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.70 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.70 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.59 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.62 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.46 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.82 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.25 | 15340226 12621046 16120746 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.26 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 15340226 16959395 18606429 8697196 16354765 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.24 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.24 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.98 | 16612254 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.98 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.88 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.48 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.97 | 12371664 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.95 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.08 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.70 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.63 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
4.04 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
4.04 | 20471514 16467208 19850784 17050201 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
4.04 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.38 | 19035177 12679006 16330433 17217047 16112521 15336539 11468182 15622746 9834237 12018890 19642359 16966277 15748426 19225113 17712046 17649720 12712474 16823087 17107899 11161223 16331271 19075265 17869043 15213294 16891316 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.68 | 16882451 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
4.73 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.73 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.34 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.34 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.56 | 15213294 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.70 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
2.36 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 19555203 11884234 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.23 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.38 | 18803445 18765137 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.29 | 11468182 19417148 15949261 19549372 14977855 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.31 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
5.12 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.89 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.89 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.29 | 16624393 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.88 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.53 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.90 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.90 | 8888407 16359493 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.47 | 16624393 19769630 12452020 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.60 | 15580305 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.47 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.47 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.82 | 11399792 11118676 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
10.82 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.60 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
3.60 | 19011039 18487222 15638997 17914592 19240160 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.98 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.48 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.29 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.91 | 1511512 14763951 11044598 16876388 3137016 15475178 11738929 17978042 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.15 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.99 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.98 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.29 | 19014326 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.36 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.68 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.92 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
2.57 | 11780464 12973940 12845720 20435036 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.00 | 8888407 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.43 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.88 | 17120751 |